You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Exploring a new direction in targeted cancer therapy through hyperbaric oxygen therapy combined with biomedical engineering techniques
- 2. The role and mechanisms of exosome microRNA in regulating metastasis within the tumor microenvironment of prostate cancer
- 3. Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties
- 4. What surviving cancer outliers can teach us: The tech behind a new paradigm in oncology
- 5. Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence
- 6. Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms
- 7. [Latest] Global Neoantigen Cancer Vaccine Market Size/Share Worth USD 1.98 Billion by 2034 at a 15.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- 8. Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
- 9. Pancreatic cancer vaccines eliminate disease in preclinical trials
- 10. Your favorite alcoholic beverage could be linked to deadly form of cancer, study finds
Last updated at 22:23 GMT
Hot News Makers
Health/Pharma Companies
-
595110.23
-
185439.77
-
65677.84
-
31598.76
-
18085.00
-
16966.99
-
11706.64
-
9596.13
-
8862.08
-
8471.98
Drugs, Treatments, Trials
-
24347.38
-
8009.50
-
7705.75
-
6397.22
-
5871.71
-
5802.28
-
5025.42
-
3978.32
-
3932.51
-
3684.53
Last updated at 22:10 GMT
